Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide
public health problems, affecting up to 25–30%(NAFLD), and up to 10–15%(CKD) of the …

Kidney tubular epithelial cells (TECs) have a crucial role in the damage and repair response
to acute and chronic injury. To adequately respond to constant changes in the environment …

The prevalence of kidney disease is increasing rapidly worldwide, reflecting rising rates of
obesity, diabetes, and associated metabolic syndrome (MetS). Chronic kidney disease and …

Metabolic syndrome (MetS) is a cluster of central obesity, dyslipidaemia, insulin resistance
and hypertension. MetS frequently co-exists with non-alcoholic fatty liver disease (NAFLD) …

Inflammatory response can be driven by cytokine production and is a pivotal target in the
management of inflammatory diseases. Monoterpenes have shown that promising profile as …

Background Metabolic syndrome with its key components insulin resistance, central obesity,
dyslipidaemia, and hypertension is associated with a high risk for cardiovascular events and …

This study aimed to investigate whether uric acid to creatinine (UA/Cr) ratio is associated
with higher risk of metabolic syndrome (MetS) and its components. 332 adult Saudi type 2 …

MicroRNAs (miRNAs) are highly conserved, small, 18–25 nucleotide, non-coding RNAs that
regulate gene expression at the post-transcriptional level. Each miRNA can regulate …

Abstract Background and Objective Psychotropic drugs are a heterogenous group of
treatments prescribed for many psychiatric disorders, often for long periods. Their effects on …

Obesity has become an important risk factor for chronic kidney disease (CKD). The
metabolically healthy obese (MHO) phenotype refers to obese individuals with a favorable …